The total return over the past 12 months is -90.34% vs. +16.94% for the S&P 500. So far it's up -78.30% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (90.34%) | (67.10%) | (66.53%) | N/A | N/A | N/A |
| Total Return CAGR | (90.34%) | (67.10%) | (66.53%) | N/A | N/A | N/A |
| Revenue CAGR | (28.12%) | (53.75%) | (62.43%) | +51.14% | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Co-Diagnostics, Inc. (CODX)
| Year | Start price | End price | CODX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $5.07 | $1.10 | (78.30%) | +14.51% | (92.81%) |
| 2025 | $22.50 | $5.07 | (77.47%) | +17.72% | (95.19%) |
| 2024 | $39.90 | $22.50 | (43.61%) | +24.89% | (68.50%) |
| 2023 | $75.60 | $39.90 | (47.22%) | +26.19% | (73.41%) |
| 2022 | $267.90 | $75.60 | (71.78%) | (18.17%) | (53.61%) |
| 2021 | $279.00 | $267.90 | (3.98%) | +28.74% | (32.72%) |
| 2020 | $26.85 | $279.00 | +939.11% | +18.37% | +920.74% |
| 2019 | $44.70 | $26.85 | (39.93%) | +31.22% | (71.15%) |
| 2018 | $79.20 | $44.70 | (43.56%) | (4.56%) | (39.00%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
